Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study
about
Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of ChinaWeek 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patientsModeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort StudyMulti-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.Determinants of Mortality among Adult HIV-Infected Patients on Antiretroviral Therapy in a Rural Hospital in Southeastern Nigeria: A 5-Year Cohort Study.Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database.A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the CaribbeanThe Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort study.Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar.Systematic review of statistically-derived models of immunological response in HIV-infected adults on antiretroviral therapy in Sub-Saharan AfricaHIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.Outcomes of antiretroviral therapy among younger versus older adolescents and adults in an urban clinic, Zimbabwe.Nutritional status and its effect on treatment outcome among HIV infected clients receiving HAART in Ethiopia: a cohort studyIncreases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South AfricaClinical Outcomes of Tenofovir Versus Zidovudine-based Regimens Among People Living with HIV/AIDS: a Two Years Retrospective Cohort Study.Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa.Zidovudine- versus Tenofovir-Based Antiretroviral Therapy for the Initial Treatment of HIV Infection in the Ethnic Minority Region of Liangshan Prefecture, Sichuan Province, China.Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).Impact of choice of NRTI in first-line antiretroviral therapy: a cohort analysis of stavudine vs. tenofovir.Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.Time to development of adverse drug reactions and associated factors among adult HIV positive patients on antiretroviral treatment in Bahir Dar City, Northwest Ethiopia.Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV.Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.Treatment Outcome and Adverse Events of Tenofovir Disoproxil Fumarate Based Regimens as Compared to Zidovudine Based Regimens Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis of Observational Studies.Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell countsComparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital
P2860
Q28354095-0D9CFC94-05B0-430C-A0A9-3EA8C7D8E32EQ28545183-15B4276B-A8B1-4FC0-8EEC-7A27074EFDC0Q28555157-F922FBE0-F093-4F99-BEB2-3904767D1092Q33846390-40427D8B-3BE6-4F07-AFF6-3E5102439DC6Q34073327-DEA8242C-98FE-4991-97DA-F2A35C347723Q34277977-068DDC1B-B967-417C-AEED-D51EF36C49BAQ35217508-3280318D-F52B-42FD-AD1F-E690DAADDC45Q35534418-D2C243B4-84F4-48B9-A286-F96FD6D2F6A8Q35589775-19D6D0C5-8B0F-4011-AE25-7D876776ADDCQ35930384-8C338DAA-E25A-49F1-A98B-0C2CCCCA753AQ35975345-C1EBEAEC-158A-4BEC-8C51-C2EEF8C7EE63Q36098892-24B3233A-5F37-48DB-8FB7-0FECF9615432Q36281213-EFF82D77-A883-4890-A320-61E1C4399301Q36977381-FBE0AD52-8DD3-4FE9-9EFD-FC7D58A14332Q37020577-33C71FFF-A2D8-4A1F-8B11-17743CAF372DQ37278636-49983084-E18F-4E18-9A52-2E74823DBE78Q37330398-95755B92-94C7-4888-9FDC-1A51684056B1Q37635145-7825235A-17CD-4266-A7B0-E520A66C0BBCQ38404966-E57F3D8E-A84B-4749-BE84-97052C766783Q39155393-8EE64819-AF72-48D5-BE91-1BF5C8BD8761Q39174707-4E8263EC-8B89-402E-94BC-E4F1E111E4D3Q40388540-22FFF1FD-1E6C-4C75-9FD4-FCE5B3C06C83Q41007911-0C3E7D1E-2364-4590-A19D-DDB8383EC97DQ42234057-A7810624-847C-403C-A5B7-1DBFA4D9B8E8Q47098773-A6B2E7EA-4487-44D8-B832-5BB9688967D7Q47267828-877313F7-EBDB-4B4C-8923-8DDB6629B0BAQ47568887-2725FC44-C5FE-4B53-959F-D8105AF23496Q48206484-CFBAF58F-5BE4-459E-A354-FB0232B63181Q55436397-5BD990E7-A7A2-4B44-B7C6-20582BB18499Q55692816-424C299B-930C-4EC8-95D6-5CA9BD3EFD76Q56909177-56DC0C1C-1077-4A12-B782-682868002B99Q58122670-57FDBF69-501D-4B01-938E-925AD9597B02
P2860
Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@ast
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@en
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@nl
type
label
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@ast
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@en
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@nl
prefLabel
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@ast
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@en
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@nl
P2860
P50
P3181
P1433
P1476
Comparison of tenofovir, zidov ...... imited-setting: a cohort study
@en
P2093
Alison D Grant
Kavindhran Velen
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0064459
P407
P577
2013-01-01T00:00:00Z